Diagnostic Manual Akkreditiertes Prüflaboratorium Register-Nr. AKS-P-20312-EU
Staatlic he Akkred itierun g sstelle Hann o ver
State of the Art of CSF Diagnostic Methods Irene Greiser-Wilke Institute of Virology Department of Infectious Diseases EU Reference Laboratory for CSF University of Veterinary Medicine Hannover 30559 Hannover, Germany
Content of the Diagnostic Manual
Laboratory Diagnosis of CSF
• Description of the disease • Guidelines to recognise suspect holdings
INDIRECT
DIRECT
• Checking and sampling procedures Virus isolation
• Collection and transport of samples • Virological tests • Serological tests
.1 m 01 o r f as
02 1.20
• Genetic typing of virus isolates
Antigen detection - FAT - ELISA (Ag)
Antibody detection - Neutralisation test - ELISA (Ab)
Nucleic acid - RT-PCR
• Safety requirements for CSF laboratories Depner, 2003
Depner, 2003
Primary Outbreak
Secondary Outbreak
clinical signs of CSF
clinical signs, epidemiology
AgELISA, FAT, PCR one test positive FAT and PCR or FAT and AgELISA or AgELISA and PCR positive
AgELISA, FAT, PCR one test positive Virus isolation positive
Virus isolation positive
Serology positive AbELISA, VNT
Virus isolation Confirmation of CSF
Confirmation of CSF Depner, 2003
Depner, 2003
1
CSF Antigen ELISA Diagnostic Manual, 2002
New Developments
Each NSFL is in charge for the licensing of different batches of commercial CSF antigen ELISAs. The CRL does not recommend a specific antigen ELISA. At present, CSF antigen ELISAs can be obtained from: Bommeli, CH Synbiotics, F ID-Lelystad, NL IDEXX, USA and S
• Antigen ELISAs • Antibody-ELISAs • RT-PCR methods
• Low sensitivity • Allowed for herd screening only
Positive samples
Evaluation of 5 Commercially available AbAb-ELISAELISA-Kits* Kits*
(from animal experiments)* experiments)* ELISA
14 d.p.i. n pos
• Ceditest CSFV (Cedi-Diagnostics)(E2) • Ceditest CSFV 2.0 (Cedi-Diagnostics)(E2) – Currently not on the market • Herdchek CSFV/Ab (IDEXX)(E2) • Chekit-CSF-Sero (Bommeli, now IDEXX)(E2) • Chekit-CSF-Marker (Bommeli, now IDEXX)(Erns)
21 d.p.i.
%
n
pos
%
n pos %
VNT
81
57
70.4
63
56
88.9
68 63 92.6
Ceditest CSFV
118 38
32.2
75
66
88.0
75 67 89.3
Ceditest CSFV 2.0
118 44
37.3
75
65
86.7
75 67 89.3
Herdchek CSFV/Ab
118 39
33.1
75
67
89.3
75 68 90.7
Chekit-CSF-Sero
118 63
53.4
75
70
93.3
75 71 94.7
Chekit-CSF-Marker
117 57
48.7
74
65
87.8
75 67 89.3
* Willie Loeffen, Sjaak Quak, 2005
Negative Field Samples (finishing pigs)* pigs)* ELISA
28 d.p.i.
* Willie Loeffen, Sjaak Quak, 2005
PanPan-pesti Positive Field Samples*
n
Positive
Specificity
Ceditest CSFV
792
2
99.7%
Ceditest CSFV 2.0
792
0
100%
Herdchek CSFV/Ab
792
0
Chekit-CSF-Sero
792
Chekit-CSF-Marker
792
n
Positive
% positive
Ceditest CSFV
173
16
9.2%
Ceditest CSFV 2.0
156
0
0%
100%
Herdchek CSFV/Ab
166
0
0%
34
95.7%
Chekit-CSF-Sero
156
3
1.9%
8
99.0%
Chekit-CSF-Marker
173
78
45.1%
* Willie Loeffen, Sjaak Quak, 2005
ELISA
* Willie Loeffen, Sjaak Quak, 2005
2
Summary* Summary*
Preliminary Conclusions* Conclusions*
Sensitivity VNT most sensitive at 14 d.p.i., compares to ELISAs after that Chekit-CSF-Sero consistently most sensitive ELISA Chekit-CSF-Marker compares to other ELISAs - More sensitive at 14 d.p.i. - More sensitive with certain strains (Paderborn)
• ELISA’s overall performance more or less comparable • Higher sensitivity goes together with lower specificity • In the test system ELISA-VNT, sensitivity of VNT will limit overall sensitivity
Specificity (random CSFCSF-negative samples) Chekit-CSF-Sero least specific ELISA, followed by Chekit-CSF-Marker Other ELISA’s comparable with very few false positives (Herdchek none at all) * Willie Loeffen, Sjaak Quak, 2005
RTRT-PCR: detection of viral genomic fragments
* Willie Loeffen, Sjaak Quak, 2005
PCR: Theory
• The DNA-polymerase used in PCR can only amplify DNA • As pestiviruses are RNA viruses, the first step to be performed is Reverse Transcription
2n
GelGel-based RTRT-PCR protocols
Evaluation Agarose gel electrophoresis
Real-time (qPCR)
• most diagnostic RT-PCRs amplify a region in the UTR • several different protocols are being used, e.g.
1. VILCEK et al. 1994 (PanPesti) 5‘ UTR 288bp -----------------------------------------------------------------------------------------------2. KATZ et al. 1993 (CSFV) E2 308bp/172bp 3. DIAZ DE ARCE et al. 1998 (CSFV)
NS5B
174bp
4. GREISER-WILKE et al. 1998 (CSFV) 5’ UTR
402bp
5. AGÜERO et al. 2004 (CSFV)
133bp
5’ UTR
3
Specificity
What is realreal-time PCR?
KATZ protocol CSFV 0518 / neg / BDV D27/99 Chemnitz
• Technique that allows direct monitoring of a PCR reaction as it occurs • It measures and quantifies fluorescent signals
„nested PCR“
• Machines: integrated thermocyclers allowing computer-assisted evaluation (fluorescence signals; photomultipliers)
308bp
172bp
• Fluorescent label in the reaction needed • Labels can be direct or indirect
Evaluation of realreal-time PCR • Increase of fluorescence proportional to increase of product (linear correlation) • Fluorescence is monitored during each PCR cycle providing an amplification plot
Evaluation Methods: Methods: Direct Fluorescent Labelling Use of dsDNA intercalating dyes (SYBR Green 1)
Fluorescence
Baseline
dR threshold
Ct
Cycle #
PestivirusPestivirus-specific RTRT-PCR (SybrGreen) SybrGreen) • PCR with pestivirus-specific primers V324/V326 (Vilcek et al., 1994) • RNA was isolated from PK15(A) cells infected with Alfort/187
Advantages/disadvantages Advantages/disadvantages of intercalating dyes + Universal applicability – You can use it for any PCR (in theory) + High signals – Every DNA molecule binds many dye molecules + Specificity can be checked by melting curve analysis - But: no real differentiation between correct product and artefacts! + Low reagent costs - Cannot multiplex - Low specificity
4
Evaluation Methods: Methods: TaqMan probes (2)
Evaluation Methods: Methods: TaqMan probes (1)
Taq DNADNA-Polymerase (5' nuclease activity) activity)
CSFVCSFV-specific TaqMan Nested RTRT-qPCR 5`
CSFVCSFV-specific TaqMan RTRT-qPCR
UTR
Primer 324
UTR
PANPESTI AMPLICON
Primer 326 Position 395395- 375
Position 108 - 128
Primer A11
3`
PANPESTI AMPLICON
5`
UTR
UTR
Primer A11
PANPESTI AMPLICON
Position 161161-186
Primer A14 Position 353353-373
210 bp
Primer A14
CSFV probe
Position 353353-373
Position 161161-186
3`
286 - 310
CSFV Probe 286 - 310
McGoldrick et al., 1998
Specificity
Sensitivity Alfort/187 Alfort/187
CSFV 422 CSFV 657
107,6
106,6 105,6 104,6 103,6 102,6
BVDV-NADL BDV-Moredun BDV-Chemnitz
101,6
5
Advantages/disadvantages Advantages/disadvantages of TaqMan Probes
Advantages of realreal-time PCR - evaluation is performed during PCR („real time“)
+ Multiplexing capability – Useful for quantification (internal control) + High specificity – Target specific due to complementary probes + High reagent costs (probe) - No size determination of the amplicon - No exclusion of contamination / probe degradation - Size of the target to be amplified limited to about 150 base pairs to obtain a maximum efficiency
Comparative Performance of Diagnostic Tests*
- electrophoresis not necessary - high sensitivity (1-20 pg) - high specificity (hybridisation, melting curves) - high sample throughput in short time - reduced contamination risk („closed tube“ PCR) - allows quantification of PCR products - fully automised procedure - expensive equipment - amplicons can not be sequenced
Conclusions • According to EU regulations, both antigen and antibody tests have to be performed in the national reference laboratories • Performance is monitored in yearly ring tests • Virus isolation and virus neutralisation are still the „gold standards“ • Due to low sensitivity antigen-ELISAs are only useful for herd testing • They are continously being replaced by RT-PCR
Reference test: virus isolation
* Dewulf et al., 2004
• Performance of commercially available antibody-ELISAs has increased
References
Any questions??? questions???
Aguero, M., J. Fernandez, L.J. Romero, M.J. Zamora, C. Sanchez, S. Belak, M. Arias, and J.M. Sanchez-Vizcaino, 2004. A highly sensitive and specific gel-based multiplex RT-PCR assay for the simultaneous and differential diagnosis of African swine fever and Classical swine fever in clinical samples. Vet Res 35:551-563. Depner, K., 2003. In: Workshop on CSF: Clinical signs, epidemiology and control. Hannover, October 6 - 9 Diaz-de-Arce H., Nunez J.I., Ganges L., Barreras M., Frias M.T., and F. Sobrino, 1998. An RTPCR assay for the specific detection of classical swine fever virus in clinical samples. Vet. Res. 29:431-440. Greiser-Wilke I., Depner K., Fritzemeier J., Haas L., and V. Moennig, 1998. Application of a computer program for genetic typing of classical swine fever virus isolates from Germany. J. Virol. Meth. 75:141-150. Katz J.B., Ridpath J.F., and S.R. Bolin, 1993. Presumptive diagnostic differentiation of hog cholera virus from bovine viral diarrhea and border disease viruses by using a cDNA nested-amplification approach. J. Clin. Microbiol. 31:565-568. Loeffen W., and S. Quak, 2005. In: Annual Meeting of National Swine Fever Laboratories, Brussels, Belgium, May 11-12 Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Part 2, Section 2.1., Chapter 2.1.13, Classical Swine Fever http://www.oie.int/eng/normes/mmanual/A_00036.htm McGoldrick A., Bensaude E., Ibata G., Sharp G., and D.J. Paton, 1999. Closed one-tube reverse transcription nested polymerase chain reaction for the detection of pestiviral RNA with fluorescent probes. J. Virol. Meth. 79:85-95. Vilcek S., Herring A.J., Nettleton P.F., Lowings J.P., and D.J. Paton, 1994. Pestiviruses isolated from pigs, cattle and sheep can be allocated into at least three genogroups using polymerase chain reaction and restriction endonuclease analysis. Arch. Virol. 136:309-323.
6